ATE402932T1 - Neue tetracyclische tetrahydrofuranderivate - Google Patents

Neue tetracyclische tetrahydrofuranderivate

Info

Publication number
ATE402932T1
ATE402932T1 AT05752829T AT05752829T ATE402932T1 AT E402932 T1 ATE402932 T1 AT E402932T1 AT 05752829 T AT05752829 T AT 05752829T AT 05752829 T AT05752829 T AT 05752829T AT E402932 T1 ATE402932 T1 AT E402932T1
Authority
AT
Austria
Prior art keywords
tetrahydrofuran derivatives
tetracyclic tetrahydrofuran
new tetracyclic
new
derivatives
Prior art date
Application number
AT05752829T
Other languages
English (en)
Inventor
Jose Maria Cid-Nunez
Antonius Adrianus Hendr Megens
Andres Avelino Trabanco-Suarez
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34957878&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE402932(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE402932T1 publication Critical patent/ATE402932T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
AT05752829T 2004-06-14 2005-06-13 Neue tetracyclische tetrahydrofuranderivate ATE402932T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP2004051105 2004-06-14

Publications (1)

Publication Number Publication Date
ATE402932T1 true ATE402932T1 (de) 2008-08-15

Family

ID=34957878

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05752829T ATE402932T1 (de) 2004-06-14 2005-06-13 Neue tetracyclische tetrahydrofuranderivate

Country Status (15)

Country Link
US (1) US20070197525A1 (de)
EP (1) EP1761514B1 (de)
JP (1) JP2008502649A (de)
CN (1) CN1968942B (de)
AR (1) AR049512A1 (de)
AT (1) ATE402932T1 (de)
AU (1) AU2005251948A1 (de)
CA (1) CA2567847A1 (de)
DE (1) DE602005008596D1 (de)
DK (1) DK1761514T3 (de)
ES (1) ES2311228T3 (de)
PL (1) PL1761514T3 (de)
PT (1) PT1761514E (de)
TW (1) TW200612899A (de)
WO (1) WO2005121113A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2604165A1 (en) * 2005-05-26 2006-11-30 Janssen Pharmaceutica N.V. Novel substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives and their use as a medicament
EP2727585A1 (de) 2006-05-16 2014-05-07 Takeda Pharmaceutical Company Limited In-vivo Screening-Methode
EP2789338A3 (de) 2007-11-15 2015-01-14 Takeda Pharmaceutical Company Limited Kondensiertes Pyridinderivat und seine Verwendung
MX2011006463A (es) 2008-12-19 2011-07-20 Supernus Pharmaceuticals Inc Metodo de tratamiento de agresion.
WO2011123497A1 (en) 2010-03-31 2011-10-06 Supernus Pharmaceuticals Inc. Stabilized formulations of cns compounds
CN103874697A (zh) * 2011-08-03 2014-06-18 协和发酵麒麟株式会社 二苯并氧杂*衍生物
WO2013189920A1 (en) 2012-06-19 2013-12-27 Ucb Pharma S.A. New compound based on cinchona alkaloïds for use in asymmetric michael addition
US20210052600A1 (en) 2017-12-27 2021-02-25 Takeda Pharmaceutical Company Limited Therapeutic agents for stress urinary incontinence and incotinence of feces

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507920A (en) * 1964-10-16 1970-04-21 Sterling Drug Inc Hydroxydibenzo(a,d)cyclohepten-5-ones and esters and ethers thereof
US3565956A (en) * 1964-10-16 1971-02-23 Sterling Drug Inc Amino-lower-alkoxy-5-alkylidene-dibenzo(a,d)cycloheptenes
US3562331A (en) * 1964-10-16 1971-02-09 Sterling Drug Inc Amino-lower-alkoxy-dibenzo(a,d)cycloheptene-5-carbinols
US3350405A (en) * 1964-10-16 1967-10-31 Sterling Drug Inc Amino-lower-alkoxy-dibenzo [a, d] cyclohepten-5-ones and 10, 11-dihydro derivatives thereof
US3812119A (en) * 1969-11-21 1974-05-21 Ciba Geigy Corp Dibenzocycloheptenes
ES2196328T3 (es) * 1996-04-12 2003-12-16 Janssen Pharmaceutica Nv Derivados de tetrahidrofurano tetraciclicos sustituidos.
UA52778C2 (uk) * 1997-10-10 2003-01-15 Янссен Фармацевтика Н.В. Галогенозаміщені тетрациклічні похідні тетрагідрофурану, спосіб їх отримання та композиція на їх основі
KR20050044329A (ko) * 2001-12-07 2005-05-12 얀센 파마슈티카 엔.브이. 트랜스-융합된3,3ａ,8,12ｂ-테트라히드로-2Ｈ-디벤조[3,4:6,7]시클로헵타[1,2-ｂ]푸란 유도체의 제조

Also Published As

Publication number Publication date
DE602005008596D1 (de) 2008-09-11
US20070197525A1 (en) 2007-08-23
ES2311228T3 (es) 2009-02-01
JP2008502649A (ja) 2008-01-31
EP1761514A1 (de) 2007-03-14
WO2005121113A1 (en) 2005-12-22
AR049512A1 (es) 2006-08-09
CA2567847A1 (en) 2005-12-22
TW200612899A (en) 2006-05-01
PL1761514T3 (pl) 2009-01-30
EP1761514B1 (de) 2008-07-30
PT1761514E (pt) 2008-10-28
DK1761514T3 (da) 2008-12-01
CN1968942A (zh) 2007-05-23
CN1968942B (zh) 2011-06-15
AU2005251948A1 (en) 2005-12-22

Similar Documents

Publication Publication Date Title
ATE413874T1 (de) Neue thiophen-derivate als sphingosin-1-phosphat- 1-rezeptorantagonisten
IS8578A (is) 3- karbamoýl - 2- pýridón afleiður
DE602005027445D1 (de) Neue zusammensetzungen mit chinolin-verbindungen
DE602007003343D1 (de) Neue mikrobiozide
ATE394399T1 (de) Tetrahydropyridoindolderivate
ATE523195T1 (de) Neue thiophen-derivate als sphingosin-1-phosphat- 1-rezeptorantagonisten
ATE540935T1 (de) Chinazolinderivate
ATE383361T1 (de) Pyrrazolopyrimidinderivate
ATE553079T1 (de) Heteroarylphenylharnstoffderivat
ATE415385T1 (de) Hexafluorisopropanolsubstituierte etherderivate
ATE387440T1 (de) Neue 4-benzylidenpiperidinderivate
ATE417830T1 (de) Sulfonylbenzimidazolderivate
ATE466857T1 (de) Neue piperidin-antibiotika
DE602005007714D1 (de) Neue quaternisierte chinuclidinester
DE602005023145D1 (de) Neue androgene
ATE425167T1 (de) Neue pyridothienopyrimidinderivate
ATE430142T1 (de) Phenylpiperazin-methanon-derivate
SE0400898L (sv) Flytkonstruktion
ATE402932T1 (de) Neue tetracyclische tetrahydrofuranderivate
ATE404542T1 (de) 4-phenylpyrimidin-2-carbonitrilderivate
ATE524461T1 (de) Neue substituierte piperidylpropanthiole
EP1806563A4 (de) Codierer
ATE365731T1 (de) 4-amino-5-cyanopyrimidinderivate
ATE445604T1 (de) Neue 2,6-diaminopyridin-3-on-derivate
ATE369347T1 (de) Trimere makrocyclisch substituierte halogen- benzolderivate

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1761514

Country of ref document: EP